[Therapy of primary aldosteronism].
作者信息
Stimpel M, Dralle H, von zur Mühlen A
出版信息
Dtsch Med Wochenschr. 1986 Sep 26;111(39):1487-8. doi: 10.1055/s-2008-1068658.
PMID:3757810
Abstract
摘要
相似文献
1
[Therapy of primary aldosteronism].
Dtsch Med Wochenschr. 1986 Sep 26;111(39):1487-8. doi: 10.1055/s-2008-1068658.
2
Primary aldosteronism.
N Engl J Med. 1998 Dec 17;339(25):1828-34. doi: 10.1056/NEJM199812173392507.
3
Primary hyperaldosteronism.
Mater Med Pol. 1983 Jul-Dec;15(3-4):117-23.
4
Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
J Hypertens Suppl. 1984 Dec;2(3):S259-61.
5
[Normokalemic primary hyperaldosteronism].
Dtsch Med Wochenschr. 2006 Nov;131(46 Spec No):H24-7. doi: 10.1055/s-2006-955058.
6
Clinical manifestation of aldosteronoma.
Surg Clin North Am. 2004 Jun;84(3):887-905. doi: 10.1016/j.suc.2004.02.001.
7
Primary aldosteronism.
Endocrinol Metab Clin North Am. 1995 Sep;24(3):593-612.
8
Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Am J Hypertens. 1995 Sep;8(9):884-93. doi: 10.1016/0895-7061(95)00182-O.
9
Primary aldosteronism and malignant adrenocortical neoplasia.
Trans Am Clin Climatol Assoc. 1975;86:163-72.
10
[Hypertension secondary to primary aldosteronism].
Nihon Rinsho. 2004 Mar;62 Suppl 3:521-5.
引用本文的文献
1
Therapeutic value of calcium antagonists in autonomous hyperaldosteronism.
Klin Wochenschr. 1989 Feb 15;67(4):248-52. doi: 10.1007/BF01717327.
Zotero 插件